Table 1.
KEGG pathway enrichment analysis of DEGs between two groups
| Term | Count | PValue | Input |
|---|---|---|---|
| Steroid biosynthesis | 8 | 0.000 | SQLE, TM7SF2, DHCR24, FDFT1, EBP, DHCR7, SC5D, MSMO1 |
| Metabolic pathways | 26 | 0.000 | ME1, FDFT1, HMGCR, QPRT, IDI1, IMPA2, HPSE, EBP, DHCR24, AKR1C3, ACOX2, MVK, CSGALNACT1, FDPS, SQLE, MVD, PLPP3, ACACA, HMGCS1, MSMO1, GK, TM7SF2, SC5D, ARG2, DHCR7, SDS |
| Terpenoid backbone biosynthesis | 6 | 0.000 | FDPS, MVD, HMGCR, HMGCS1, MVK, IDI1 |
| PPAR signaling pathway | 7 | 0.000 | ME1, PPARD, GK, LPL, PLIN2, ACOX2, FADS2 |
| Hematopoietic cell lineage | 5 | 0.000 | CSF1R, CD1E, CD14, CSF1, CSF2RA |
| Transcriptional misregulation in cancer | 6 | 0.000 | NR4A3, CD14, NUPR1, ETV5, CSF1R, DUSP6 |
| Cytokine-cytokine receptor interaction | 7 | 0.000 | CXCL2, CCL4, CXCR4, CCL7, CSF2RA, CSF1R, CSF1 |
| ABC transporters | 3 | 0.001 | ABCB9, ABCG1, ABCA1 |
| MAPK signaling pathway | 6 | 0.002 | DUSP5, CD14, GADD45A, CD14, GADD45A, DUSP6, DUSP2, PTPRR |
| Glycerolipid metabolism | 3 | 0.003 | GK, LPL, PLPP3 |